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Antibody response to sand fly saliva is
a marker of transmission intensity but
not disease progression in dogs naturally
infected with Leishmania infantum
Rupert J. Quinnell1*†, Seyi Soremekun2,3†, Paul A. Bates4, Matthew E. Rogers3, Lourdes M. Garcez5,6
and Orin Courtenay2*
Abstract
Background: Antibody responses to sand fly saliva have been suggested to be a useful marker of exposure to sand
fly bites and Leishmania infection and a potential tool to monitor the effectiveness of entomological interventions.
Exposure to sand fly bites before infection has also been suggested to modulate the severity of the infection. Here,
we test these hypotheses by quantifying the anti-saliva IgG response in a cohort study of dogs exposed to natural
infection with Leishmania infantum in Brazil.
Methods: IgG responses to crude salivary antigens of the sand fly Lutzomyia longipalpis were measured by ELISA in
longitudinal serum samples from 47 previously unexposed sentinel dogs and 11 initially uninfected resident dogs
for up to 2 years. Antibody responses were compared to the intensity of transmission, assessed by variation in the
incidence of infection between seasons and between dogs. Antibody responses before patent infection were then
compared with the severity of infection, assessed using tissue parasite loads and clinical symptoms.
Results: Previously unexposed dogs acquired anti-saliva antibody responses within 2 months, and the rate of
acquisition increased with the intensity of seasonal transmission. Over the following 2 years, antibody responses varied
with seasonal transmission and sand fly numbers, declining rapidly in periods of low transmission. Antibody responses
varied greatly between dogs and correlated with the intensity of transmission experienced by individual dogs, measured
by the number of days in the field before patent infection. After infection, anti-saliva antibody responses were positively
correlated with anti-parasite antibody responses. However, there was no evidence that the degree of exposure to sand fly
bites before infection affected the severity of the infection.
Conclusions: Anti-saliva antibody responses are a marker of current transmission intensity in dogs exposed to natural
infection with Leishmania infantum, but are not associated with the outcome of infection.
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Background
Haematophagous arthropod disease vectors inject saliva
into hosts when blood-feeding that invokes anti-saliva
immune responses. The detection of anti-saliva anti-
bodies in host sera is a potential tool for monitoring
changes in vector biting intensity brought about by sea-
sonality, climatic conditions, or control interventions di-
rected against the vector [1, 2]. The best current method
for evaluating individual human exposure to vector bites
is by human-landing catch counts using adult volun-
teers, but this method has ethical issues and does not
provide measures for children who are often the high-
risk group. Key to the useful application of an anti-saliva
antibody immunoassay is having a precise understanding
of the antibody kinetics in relation to changes in vector
biting pressure. Such data are best quantified through a
longitudinal study.
Phlebotomine sandflies are proven vectors for transmis-
sion of viruses (Phlebovirus and Vesiculovirus), bacteria
(Bartonella bacilliformis), and protozoa (Leishmania spp.)
that cause high morbidity, mortality and economic loss in
humans, domestic animals, and livestock [3, 4]. Sand fly
saliva contains some antigens, and both humans and other
mammals produce a strong anti-saliva antibody response
when naturally exposed to sand fly bites in endemic areas
[5–10]. Experimental exposure of naïve hosts, including
mice, dogs and humans, to sand fly bites shows that anti-
body responses to saliva are acquired rapidly, usually
within a few weeks of exposure [11–16], and that the mag-
nitude of the antibody response increases with the num-
ber of sand fly bites [11, 12, 15, 16]. The duration of
antibody responses after the experimental challenge is
more variable: no decline 24 weeks after exposure in
BALB/c mice bitten by Phlebotomus papatasi [15], but a
rapid decline in magnitude within a few weeks in dogs bit-
ten by P. perniciosus and Lu. longipalpis, though responses
remained positive in some dogs for up to 29 weeks [11,
12]. There have been fewer studies of the kinetics of anti-
body responses in naturally exposed hosts. Sentinel dogs
and chickens develop antibody responses within a few
months after their first exposure to sand fly bites [17, 18],
and there is evidence of a decline in responses when
humans and dogs cease to be exposed, though the magni-
tude of this decline is variable [8, 18]. Only one field study
has compared anti-saliva antibody responses to an
entomological measure of exposure; human anti-saliva
antibody responses showed a positive but non-linear rela-
tionship with the number of female Ph. argentipes trapped
inside houses in India and Nepal [8].
Exposure to sand fly bites also induces a strong cellular
immune response to saliva [14, 19]. Studies of cutaneous
leishmaniasis in rodent models have shown that exposure
to sand fly bites, or immunization with salivary gland
homogenate, prior to infection reduces the severity of
subsequent experimental infection [20]. This effect is asso-
ciated with a Th1 response to salivary antigens (reviewed
by [19]). Pre-exposure to salivary gland proteins has also
been associated with a lower severity of visceral leishman-
iasis in the hamster model [21]. These results suggest that
inclusion of salivary gland proteins in future vaccines
could contribute to providing protection; partial protec-
tion against L. major infection has been shown recently in
experimental macaques vaccinated with a P. duboscqi sal-
ivary protein [22]. However, it is less clear what the role is
of sand fly induced host responses under natural condi-
tions. Some cross-sectional field studies have shown that
increased anti-saliva antibodies are correlated with the risk
of infection [9, 23], and in some cases also the severity of
infection [9, 23], but the interpretation of such cross-
sectional studies is difficult. There have been no published
longitudinal field studies that have compared the degree
of pre-exposure to bites with the severity of natural Leish-
mania infantum infection.
Zoonotic visceral leishmaniasis (ZVL) is a fatal disease
of humans caused by infection with L. infantum, for
which the domestic dog is the principal reservoir [24].
Here we use data from a cohort of naturally infected
dogs in Amazon Brazil to test whether the anti-saliva
antibody response could be used as a marker of expos-
ure to the sand fly vector Lu. longipalpis. The specific
aims were to investigate (i) the rate of acquisition of re-
sponses in previously unexposed sentinel dogs; (ii) the
rate of loss and re-acquisition of responses as a result of
seasonal variation in transmission rates; and (iii) the re-
lationship between the strength of the anti-saliva re-
sponse and the force of infection experienced by each
dog, measured by the time taken to become infected.
We then test whether the degree of prior exposure to
sand fly bites affects the severity of infection, by (iv) in-
vestigating the relationship between anti-saliva antibody
responses and the severity of infection, assessed by para-
site load and clinical symptoms.
Methods
Study site and study design
Serum samples were selected using archived material
from a prospective cohort study carried out from April
1993 to July 1995 in the municipality of Salvaterra, Mar-
ajó Island, Pará State, Brazil (48°03'W, 00°46'S). The
study design has been described previously [25, 26].
Briefly, 126 initially uninfected dogs were placed at inter-
vals within households in the study site, and sampled ap-
proximately every 2 months (mean interval 67 days,
range 58–80 days) during exposure to natural infection,
for a maximum of 27 months. Details of the study de-
sign are provided in Table 1; most dogs were placed in
the field in four initial cohorts, with the numbers in each
cohort depending on the availability of dogs and
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households. Additional dogs were placed at later times
when recipient households were available. Ninety-six
dogs became infected during the study, and all dogs that
were present for at least 8 sampling rounds became in-
fected. Due to the limited amount of salivary antigen
available, we could not test all samples, so used the in-
clusion criterion that dogs were sampled for at least
4 months (2 sampling rounds) after the date of infection.
Samples from 61 of these 65 dogs were tested, in
addition to samples from 2 other infected dogs. Unfortu-
nately, the assay of one plate of samples did not succeed,
which left 345 tested samples from 58 dogs, with an
average of 6 samples tested per dog (range 3–11 sam-
ples). Eleven of the 58 dogs were initially uninfected
resident dogs, born in the study area and so exposed to
sand fly bites since birth. The remaining 47 were senti-
nel dogs taken to the study site from the nearby non-
endemic city of Belém, and so had no previous exposure
to sand fly bites. Time of patent infection in study dogs
was defined using our previous results as the first time
point of detection of Leishmania infection by any of the
following methods: (i) detection of anti-Leishmania IgG
by ELISA using crude leishmanial antigen (CLA), with
antibody concentrations expressed as arbitrary units/ml
relative to a positive control serum [25]; (ii) PCR on
bone marrow biopsies using primers specific for kineto-
plast DNA (kDNA) and ribosomal RNA [27]; (iii) quan-
titative kDNA PCR on bone marrow and ear skin
biopsies, with results expressed as parasites/ml [28, 29].
All samples taken on or after the time of patent infec-
tion were classified as being from an infected dog. Nega-
tive control dogs comprised 6 unexposed, non-endemic
UK dogs with no history of foreign travel that had
attended two UK veterinary clinics during June to
December 2007.
Sand fly salivary gland homogenate (SGH)
Salivary glands were dissected out from laboratory colony
Lu. longipalpis sandflies (originally from Jacobina, Brazil),
and stored in PBS in aliquots of 250 μl at a concentration
of 200 pairs/ml. Glands were ruptured by 3 freeze-thaw
cycles and the homogenate stored at -80 °C. The protein
concentration of SGH was assayed using a standard
BioRad protocol (BioRad Laboratories, Hercules, USA).
Anti-Lu. longipalpis saliva ELISA
Ninety six-well ELISA plates (Linbro Scientific, Hamden,
USA) were coated with salivary gland antigen at a con-
centration of 2.5 μg/ml in carbonate coating buffer
(NaHCO3 0.45 M, Na2CO3 0.02 M, pH 9.6) at 100 μl
per well, and incubated overnight at 4 °C. Plates were
then washed 3 times with PBS-Tween (PBS pH 9.6 with
0.05% Tween-20). This was followed by blocking with
200 μl per well of 5% bovine serum albumin in PBS for
1 h at 37 °C. After 3 washes with PBS-Tween, 100 μl of
sera (diluted 1:100 and 1:200 in PBS-Tween +0.5% BSA)
was added and the plates incubated for 2 h at 37 °C.
Two-fold serial dilutions (from 1:50–1:12,800) of serum,
from a dog known to have a strongly positive reaction to
saliva, were added to each plate as a standard curve. Fol-
lowing a further wash step, alkaline phosphatase-
conjugated rabbit anti-canine IgG (Sigma-Aldrich, St.
Louis, USA) was added at a dilution of 1:1000 in PBS-
Tween-BSA to each well (100 μl/well) for 1 h at 37 °C.
Following 3 further washes, 100 μl of p-nitrophenyl
phosphate solution (Sigma-Aldrich) was added to each
Table 1 Numbers of dogs that were enrolled in the study at each sampling point, and the numbers of dogs enrolled that were
tested for anti-saliva antibody
Sampling round Midpoint date Day No. of dogs enrolled No. of tested dogs enrolled
1 11 April 1993 0 30 17
2 30 June 1993 80 21 14
3 28 August 1993 139 37 17
4 5 November 1993 208 16 4
5 13 January 1994 277 6 3
6 23 March 1994 346 2 1
7 30 May 1994 414 9 1
8 6 August 1994 482 0 0
9 12 October 1994 549 0 0
10 10 December 1994 608 5 1
11 19 February 1995 683 0 0
12 24 April 1995 746 0 0
13 6 July 1995 818 0 0
Total 126 58
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well and plates were left to develop at 37 °C for 20–
30 min. Plates were stopped with 3 M NaOH and
read at 405 nm. Negative control wells (no saliva
antigen) were included for each sample dilution on
the plate. Absorbance values of the negative controls
were then subtracted from each corresponding sam-
ple. The resultant optical density (OD) values were
then converted to units/ml using a log-logit trans-
formed standard line. The positive control serum was
assigned a value of 12,800 units/ml. All samples were
above the lower detection limit of 100 units/ml; two
samples above the higher detection limit were
assigned the value of the higher detection limit
(51,200 units/ml).
Sample storage and quality control
Serum samples were collected during 1993–1995 and ali-
quoted at the time of collection. For long-term storage,
samples were kept at -80 °C. CLA ELISA was carried out
in 1996, and salivary gland ELISA in 2006. Samples had
been briefly thawed several times by the time of salivary
gland ELISA testing. Two years after the salivary gland
ELISA analysis, a proportion of the total serum samples
(n = 242, of which n = 131 were assayed for anti-saliva
IgG) were re-tested by CLA ELISA in 2008 to confirm
continued seroreactivity. A single sample showed strongly
reduced reactivity; this sample was not part of the sub-
sample tested for anti-saliva IgG in this study. The
remaining samples showed a good agreement with the re-
sults of the initial CLA ELISA, with a strong and consist-
ent positive correlation between antibody concentrations
in 1996 and 2008 (r2 = 0.77). In 1996 and 2008 respect-
ively, 162/241 (67%) samples and 159/241 (66%) samples
were seropositive, with a high degree of concordance be-
tween years (kappa = 0.80) and no significant difference in
sensitivity (McNemar’s test, P = 0.51).
Measures of transmission intensity
The seasonal incidence of infection in study dogs was
estimated between each sampling round from follow-up
of uninfected dogs as described previously in [25]. The
11 fitted incidence estimates could be reduced to three
without significantly reducing the fit [25], and here we
use these three estimates to describe seasonal variation
in incidence. Transmission intensity experienced by indi-
vidual dogs was estimated as the incidence of infection
of each dog, i.e. 1/(the number of days to patent infec-
tion for that dog), calculated from the time the dog was
placed in the study area (Belém dogs) or the date of
birth (resident dogs). Sand fly numbers are known to
vary geographically across the study area [30]; geograph-
ical variation was modelled by using the village of resi-
dence as a variable. Sampled dogs came from 22 villages,
with 1–7 sampled dogs per village. Data on seasonal
variation of Lu. longipalpis numbers are available from a
separate study that monitored sand fly numbers in 10
untreated chicken sheds in the same study area using
CDC light traps at 8 time-points between October 1993
to June 1994 [31]. Precipitation data for 1993–1995 were
obtained from the National Institute of Meteorology
(MAARA), Belém, Brazil.
Measures of infection severity
The severity of infection was assessed using (i) the mag-
nitude of the anti-Leishmania IgG response, (ii) the
parasite burden in bone marrow and ear biopsies
assessed by qPCR as described earlier, and (iii) the clin-
ical status assessed by a clinical score. For the clinical
score, dogs were scored on a scale from 0 (absent) to 3
(intense) for six typical clinical signs of leishmaniasis
(alopecia, dermatitis, chancres, conjunctivitis, onycho-
gryphosis, and lymphadenopathy), and these scores
summed. We used the maximum anti-Leishmania anti-
body level, bone marrow parasite burden and clinical
score of each dog to classify infected dogs into three
groups: severe, recovered and mild infection. Severe in-
fection dogs were either (i) polysymptomatic (maximum
clinical score of > 6) and with a high maximum antibody
level and/or parasite load (defined as greater than the me-
dian of the maximum levels), or (ii) had high and increas-
ing levels of both anti-parasite antibodies and parasites at
their final sampling point, but were not polysymptomatic.
Since clinical score typical increases after antibody and
parasite levels, this latter group were expected to have be-
come polysymptomatic. Recovered dogs had a maximum
clinical score of > 6, but their final clinical score had re-
duced to < 3. Mild infections were defined as maximum
clinical score < 7, and both anti-parasite antibody level
and parasite load below the median.
Statistical analysis
Anti-saliva antibody responses were analysed after log10-
transformation, which normalised residuals and stabi-
lised the variance. Statistical analyses of antibody
responses against independent variables were conducted
using linear models or linear mixed models. Mixed
models with dog identity included as a random effect
were used for all analyses when > 1 sample from each
dog was included in the analysis; mixed models were
fitted by maximum likelihood, and significance of ex-
planatory variables tested by likelihood ratio tests
(LRTs). To determine the effects of prior exposure to
saliva on the severity of subsequent infection, anti-Leish-
mania antibody responses were analysed with linear
mixed models after log10 transformation, while parasite
burdens and clinical status (total clinical score) were
analysed with negative binomial mixed models. Time
(days) since the infection was controlled for by including
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linear and squared terms as covariates. For dogs where
the response to saliva one round prior to infection was
not assessed, this was estimated as the mean of the
time points before and after this. The analysis was car-
ried out in Stata 11.1, using the regress, xtmixed and
xtnbreg routines (Stata Corporation, College Station,
Texas, USA).
Results
Acquisition of anti-saliva antibody responses in sentinel
dogs
Anti-saliva antibody responses were measured in 47 senti-
nel dogs, and 11 resident dogs. Prior to exposure, i.e. before
being placed in the field, sentinel dogs showed a low
response (geometric mean 368 units/ml, SD range 211–
642 units/ml), though somewhat higher than that of 6 non-
endemic UK control dogs (geometric mean 183 units/ml,
SD range 125–269 units/ml; t(50) = 2.96, P = 0.005). Sam-
pled sentinel dogs were placed into the field as 8 cohorts of
1–15 dogs at approximately 2-month intervals. Anti-saliv-
ary antibody responses rose rapidly in each cohort
during the first 2 months in the field, with the mean
increasing by 5 to 75-fold by the end of the first
sampling period, an average of 65 days of natural exposure
(paired t-test, t(43) = 10.83, P < 0.0001; Fig. 1a). The magni-
tude of this initial rise within cohorts varied seasonally,
with the highest rises observed in dogs placed in the field
at the end of the calendar year (F(7,37) = 4.47, P = 0.0011).
This pattern reflected the seasonal variation in sand fly
numbers and the incidence of infection, which peak at the
end of the dry season in November-December and then
decline rapidly (Fig. 1b). The initial rise in anti-saliva
responses in each cohort of dogs was strongly associ-
ated with the log incidence of infection during that
period (F(1,43) = 30.3, P < 0.0001). After the initial rise,
anti-saliva antibody levels did not show a consistent
further increase during the next 65 days in the field,
increasing in three cohorts and declining in two, in
accordance with the seasonal pattern in sand fly num-
bers (Fig. 1a).
Seasonal variation in anti-saliva antibody responses
Excluding the first (pre-exposure) sample from sentinel
dogs, anti-saliva antibody responses were measured in
300 samples from 58 dogs, with an average of 5 samples
per dog (range 3–10). The geometric mean anti-saliva
Fig. 1 The initial acquisition of anti-sand fly saliva antibody responses in sentinel dogs. a The antibody response before exposure, 2 and 4 months
after being placed in the field of each cohort of dogs (geometric mean ± SE). Sample sizes for each cohort are 11, 13, 15, 2 and three dogs; three
further cohorts of a single dog each are not illustrated. b Seasonal changes in the estimated incidence of infection (dotted line) and numbers of
Lutzomyia longipalpis sand flies caught in 10 chicken sheds (data from [31])
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antibody level (SD range) was 3607 (1053–12,362) units/
ml. Follow-up of sentinel and resident dogs showed that
after the initial acquisition of anti-saliva antibody, responses
varied seasonally with the L. infantum transmission rate,
declining sharply and significantly between January and
March 1994, coincident with the decline in infection inci-
dence associated with the start of the wet season (Fig. 2).
This pattern was repeated the following year, with a signifi-
cant increase from August to December 1994 at the end of
the dry season, and then a decline from December 1994 to
April 1995 during the following wet season (Fig. 2). Overall,
anti-saliva antibody responses were significantly associated
with the seasonal incidence rate at the time of the sample
(LRT χ2 = 45.9, df = 1, P < 0.0001).
Variation in anti-saliva antibody responses between dogs
There was considerable variation between dogs in their
mean antibody response to saliva, with a nearly 50-fold
difference in mean levels (570 to 27,353 units/ml). This
variation could reflect variation in exposure to sand fly
bites or variation in host responsiveness. We used two
surrogate measures of the biting rate per dog: the num-
ber of days each dog took to develop a patent infection
(i.e. the force of infection experienced by each dog), and
the village of residence (since sand fly numbers are
known to vary geographically in the study area). Anti-
saliva antibody responses were strongly associated
with both the incidence of infection of the dog and
with the village of residence, in addition to seasonal
variations (sampling month) (Table 2). There was an
increase in anti-saliva response with increasing trans-
mission rate (Fig. 3) and mean anti-saliva responses
varied up to 33-fold between villages. In contrast,
anti-saliva responses were not associated with dog sex
or origin (resident vs sentinel) (Table 2).
Relationship between anti-saliva responses and infection
Uninfected dogs with a high level of exposure to sand-
flies were more likely to become infected at their next
sampling point: the odds of becoming infected by the
next sampling round increased by 4.39-fold (95% CL:
1.79–10.74) with every unit increase in log anti-saliva
IgG (logistic regression, LRT χ2 = 12.19, P = 0.0005). In-
fected dogs also had higher average anti-saliva responses
than uninfected dogs (LRT χ2 = 17.86, df = 1, P < 0.0001),
which reflects variation in transmission rate, and so this
difference was not significant when controlling for sea-
sonal effects (sampling month) (LRT χ2 = 0.76, P = 0.38).
In infected dogs, there was a significant positive relation-
ship between anti-saliva and anti-Leishmania IgG
Fig. 2 Seasonal variation in anti-sand fly saliva antibody responses. a Antibody responses (geometric mean ± SE). b Estimated incidence of infection
(per day) in study dogs (solid line) and monthly rainfall in mm (dotted line) during the study period
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responses, but no relationship between contemporary
anti-saliva IgG responses and Leishmania parasite bur-
dens in tissue or clinical score (Table 3).
To examine possible effects of prior exposure to sand
fly bites on the outcome of infection, we tested the rela-
tionship between the anti-saliva antibody responses mea-
sured 2 months before patent infection and the
subsequent severity of the infection. No significant rela-
tionship was found, whether the severity of infection
was assessed by the strength of the anti-Leishmania
antibody response, by the parasite burden in bone mar-
row (Fig. 4) or in-ear skin biopsies, or by clinical score
(Table 3). There was also no observed relationship be-
tween the transmission rate of each dog (measured by
some days taken to become infected) and the severity of
subsequent infection (Table 3).
To further illustrate the lack of relationship between
anti-saliva antibody levels and the outcome of infection,
we classified infected dogs into severe (n = 23), recovered
(n = 6) and mild infections (n = 18). The remaining 11
dogs could not be classified. These three groups had
very different average antibody levels and clinical
scores (Fig. 5), even though some dogs may have
been misclassified, as dogs were not followed for the
entire course of infection. However, there was no sig-
nificant difference in anti-saliva antibody levels
Table 2 Factors associated with the magnitude of the canine
anti-saliva antibody response. Effect estimates are from an
adjusted mixed model analysis with dog included as a random
effect. Full data were available for 295 samples from 58 dogs
Estimate (95% CL) LRT χ2 df P
Fixed effects
Sampling round – 119.8 12 < 0.0001
Incidence (1/days)a 1.392 (0.952–1.832) 28.73 1 < 0.0001
Village – 46.94 21 0.001
Sex 0.020 (-0.153–0.193) 0.05 1 0.82
Origin -0.093 (-0.339–0.153) 0.55 1 0.46
Random effect
Dog 0.040 (0.024–0.066)b 60.44 1 < 0.0001
Residual 0.066 (0.055–0.078)b
alog-transformed
bvariance (95% CL)
Fig. 3 The relationship between the mean anti-saliva antibody responses
of individual dogs and their incidence of infection. Incidence for each
dog (n= 58) was assessed as the inverse of the number of days in the
field to patent infection with Leishmania infantum
Table 3 Relationships between the severity of canine infection
with Leishmania infantum and the anti-saliva antibody response,
measured at the time of sampling, approximately 2 months
before patent infection, and against transmission intensity
(log incidence)
Severity measure n (samples) n (dogs) LRT χ2 P
Anti-saliva IgG at time of sampling
Anti-Leishmania IgG 206 58 7.11 0.0077
Parasites (bone marrow) 122 53 0.00 0.95
Parasites (ear skin) 80 40 0.03 0.86
Clinical score 195 58 0.00 0.97
Anti-saliva IgG prior to infection
Anti-Leishmania IgG 374 58 2.79 0.095
Parasites (bone marrow) 214 55 0.00 0.97
Parasites (ear skin) 152 47 1.09 0.30
Clinical score 361 58 0.02 0.90
Transmission intensity (log incidence)
Anti-Leishmania IgG 458 94 0.00 0.96
Parasites (bone marrow) 264 81 0.05 0.82
Parasites (ear skin) 184 63 1.51 0.22
Clinical score 439 92 1.04 0.31
Fig. 4 The relationship between the mean parasite load of individual
dogs and their anti-saliva antibody responses 2 months before patent
infection with Leishmania infantum. Parasite load was assessed as the
mean log number of parasites in bone marrow biopsies of infected
dogs (n = 55)
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between the groups of dogs at any time-point, and
levels before infection were very similar (Fig. 5).
Discussion
We provide the first description of the kinetics of anti-
sand fly saliva antibody responses in dogs exposed to
natural transmission of L. infantum by Lu. longipalpis,
and of the relationships between anti-saliva responses
and the severity of the infection. The results suggest that
the canine anti-saliva antibody response is a reliable
marker of the magnitude of current exposure to sand fly
bites and is thus a useful epidemiological tool for asses-
sing community or individual exposure to infection, and
the effects of interventions against sand fly biting rates
within ZVL control programmes. Our results show that
the strength of the anti-saliva antibody response before
infection was positively associated with the risk of infec-
tion but, in contrast to experimental studies of murine
leishmaniasis, there was no relationship between previ-
ous natural exposure to sand fly bites and the severity of
L. infantum infection in this population.
Entomological measures of sand fly biting rate have
some practical and ethical issues. The gold standard
measure, the human landing catch, is time-consuming
and ethically difficult, and cannot be performed on non-
human hosts as human collectors are needed. Indirect
measures using traps are logistically difficult. Antibodies
to sand fly saliva have been suggested to be a useful
marker for recent exposure to bites [5, 6]. A good surro-
gate measure of exposure would have a number of prop-
erties: the response should be rapidly acquired upon
exposure; it should decline when exposure falls; there
should be a positive, ideally linear, relationship between
the magnitude of the response and the degree of expos-
ure; and it should be easier to use than existing
measures. Here, previously unexposed sentinel dogs ac-
quired strong anti-saliva antibody responses within 2
months of exposure. Similarly, the rapid acquisition has
been seen in experimentally exposed rodents, dogs and
humans, with responses developing in two to 8 weeks
[11–15]. The initial level of anti-salivary antibody re-
sponses in the sentinel dogs showed some responsive-
ness compared to UK dogs. This difference may reflect
higher exposure to other biting arthropods such as mos-
quitos or fleas, or higher exposure to microbial antigens
leading to generally upregulated antibody production.
Lu. longipalpis has not been found in or around Belem,
though some forest associated sand fly species may be
found on the outskirts of the city.
To explore the loss of responsiveness as exposure de-
creases, we took advantage of the marked seasonal vari-
ation in sand fly abundance in the study area. Anti-saliva
responses fell sharply by around 50% within 2 months at
the onset of the wet season in the first months of 1994,
coincident with the decline in both sand fly numbers
and incidence of infection. A similar decline was seen
the following year; though sand fly numbers were not
monitored this year, the similar seasonal changes in inci-
dence suggest that seasonal changes in sand fly numbers
in each year were also similar. However, the decline in
antibody response was less marked than the declines in
Fig. 5 Variation in mean anti-saliva IgG responses (a), mean anti-
Leishmania IgG responses (b) and median clinical score through
time (c). Dogs were classified as severe infections (filled circles,
n = 23), recovered (crosses, n = 6) and mild infections (open circles,
n = 18). Estimated time of patent infection is indicated by the vertical
dotted line. Asterisks indicate a significant difference between groups
after sequential Bonferroni correction by ANOVA (IgG) or Kruskal-Wallis
test (clinical score) *P < 0.05, **P < 0.01, ***P < 0.001
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sandflies and incidence, suggesting only a partial loss of
titre. A similar pattern has been seen in experimentally
exposed dogs, where the antibody response declined to
about half the initial peak within a few weeks of the last
exposure but remained at this lower level for at least
19 weeks [11, 12]. Anti-saliva antibody levels to natural
exposure also showed a partial decline in both humans
and dogs in the absence of bites, although the magni-
tude of this decline appeared to be less than in the
current study [8, 18]. Therefore, where monitoring de-
clines in incidence is important, such as during control
programmes, using sentinel animals, e.g. chickens [17],
placed in the field for only a short time-period may pro-
vide a more sensitive measure of change in exposure
than monitoring resident animals with prolonged expos-
ure. Experimental studies have shown that the relation-
ship between the magnitude of the initial saliva antibody
response and the number of sand fly bites is approxi-
mately linear in both mice and dogs [11, 12, 15]. The
only previous field study of this relationship in naturally
exposed hosts showed a positive, but non-linear, rela-
tionship between human antibody responses to P. argen-
tipes and the numbers of sandflies captured within the
household; though catches inside households may not be
the best marker of exposure in that region [8, 32]. Here,
we demonstrate a strong positive relationship between
antibody responses and the incidence of L. infantum in-
fection in dogs, both for the initial response and for re-
sponses in continually exposed endemic dogs, with a
roughly linear relationship between the logarithms of
antibody response and incidence. Although testing for
anti-SGH antibodies was carried out on stored samples
several years after collection, quality control showed that
anti-leishmanial antibody levels in the stored samples
remained high, with a strong correlation with results
from the time of collection.
The major logistical issue for measuring anti-saliva re-
sponses is the limited availability of the antigen, which
requires laborious dissection and preparation of sand fly
SGH. In this respect, use of recombinant antigens would
be advantageous; two recombinant L. longipalpis salivary
antigens (rLJM11 and rLJM17) have been shown to have
high sensitivity in humans when used in combination,
and these antigens, and rLJL143, are also recognised by
dogs [14, 33, 34]. In a recent study of a geographically
different population of Brazilian dogs, we showed a close
association (r2 = 0.77, P < 0.001) between IgG responses
to SGH antigen and salivary recombinant proteins
rLJM11 and rLJL143 (Bell & Courtenay, unpublished
data). Similarly, canine responses to recombinant P. per-
niciosus antigens, and human responses to a recombin-
ant P. papatasi antigen have been shown to correlate
well with responses to SGH [18, 35–37]. Use of recom-
binant antigens should also improve the specificity of
the assay [34], as cross-reactions between salivary anti-
gens from related vector species may occur, such as Lu.
longipalpis and Lu. intermedia [34], and P. papatasi and
P. argentipes [8], which can complicate interpretation for
areas where more than one sand fly species is common.
However, in the current study area, lack of specificity
was unlikely to be an issue, as Lu. longipalpis is the only
abundant peridomestic species, comprising up to 99% of
peridomestic captures [31, 38, 39]. Conversely, antigens
from the whole saliva are more likely to be post-
translationally modified and folded correctly and there-
fore active, with immunogenic proteins present in
correct ratios. Care is needed in the selection of single
proteins, or combinations, as they may elicit different or
weak immune responses compared to SGH [34, 40, 41].
Anti-saliva responses varied greatly between individual
dogs. Some of this variation may reflect differences in
general antibody responsiveness between dogs, as the
strength of response varies between dogs of a single
breed experimentally exposed to a known number of
bites [11]. However, the strong correlation with infection
incidence shows that much of the variation is due to
variation in exposure to sand fly bites. The observed
variation between villages was consistent with the known
variation in sand fly numbers across the study area: the
villages with lowest antibody responses were in mostly
open savannah grassland and riverine forest habitats,
which have lower sand fly numbers [30], and also the
peri-urban areas [42]. However, there was up to 20-fold
variation in antibody response between dogs in the same
village, which suggests a high variation in biting rate be-
tween dogs at small spatial scales, also consistent with
high levels of variation in peridomestic sand fly numbers
within villages [30]. These data indicate that a large sam-
ple size will be needed for precise measurement of com-
munity exposure. There was also a positive relationship
between anti-saliva and anti-parasite antibody responses,
previously shown in European dogs [18]. This is likely to
reflect both the generalized up-regulation of antibody re-
sponses in visceral leishmaniasis and innate differences
between dogs in their antibody responsiveness.
Exposure to sand fly bites, or immunization with SGH
or defined antigens, has been shown to provide partial
protection against subsequent infection with L. major
and L. amazonensis in rodent models, with protection
demonstrated by a reduction in pathology and/or para-
site load (reviewed by [19, 20]), and also recently in non-
human primates [22]. For L. braziliensis both protection
and exacerbation of infection have been reported, depend-
ing on the species of sand fly saliva and type of antigen [9,
43]. Fewer studies have been performed using visceralizing
parasites, but immunization with defined antigens from
Lu. longipalpis saliva provided partial protection against
infection with L. infantum in hamsters and enhanced
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protective immune responses in dogs [14, 21]. Confirm-
ation of these effects in the field has proven difficult, in
part because of the difficulty in distinguishing potential ef-
fects of exposure to sand fly saliva from those of transmis-
sion intensity [44]. In the present study, there was a
strong positive association between the strength of anti-
saliva responses before infection and the risk of being in-
fected. Similar positive associations between anti-saliva re-
sponses and the presence or timing of infection have been
seen in field studies of human cutaneous leishmaniasis
and VL [5, 9, 10, 23, 44–46], though not in a study of
European dogs [11]. However, such positive associations
are expected, given variation in exposure to bites between
hosts and between seasons; they do not imply that expos-
ure to sand fly saliva increases the risk of infection, merely
that hosts that are bitten more are more likely to become
infected, since sand fly infection rates are low (typically
< 2%) [47–49]. This positive association between anti-
saliva responses and exposure to parasites complicates the
identification of potential protective effects of saliva in the
field, though there are suggestions of both protective and
exacerbatory effects of saliva in human studies [9, 45].
To our knowledge, this study is the first field investiga-
tion to explicitly test the hypothesis that anti-saliva anti-
body responses before infection affect the severity of
subsequent infection under endemic conditions. We
found no relationship between prior exposure to sand fly
bites, as measured by the strength of pre-infection anti-
saliva antibody responses, and the severity of infection,
assessed by parasite load or clinical score. We also found
no relationship between infection outcome and the
transmission rate. These results are based on measure-
ments of a broad spectrum of immunological and para-
sitological infection outcomes following natural infection
in outbred dogs and associated with carefully measured
estimates of the temporal transmission intensity. There
are several possible reasons why the protective effect of
prior exposure to sand fly saliva seen in experimental in-
fection was not seen in the field. One key factor is that,
since natural sand fly infection rates are low, nearly all
dogs will have been exposed to a large number of bites
from uninfected sand flies, for an extended period, be-
fore they become infected. Chronic exposure to unin-
fected sand fly bites has been shown to remove the
protective effect against experimental L. major infection
[50]. It is also possible that more sophisticated measures
of anti-saliva immunity may be necessary to demonstrate
any effect since the protective effect in experimental in-
fection has been shown to be due to cell-mediated, not
humoral, immune responses to only certain sand fly an-
tigens [14, 21, 41]. In endemic areas, hosts with a high
biting rate will repeatedly be exposed to parasites once
infected, which could also have a modulatory effect on
the course of infection [51]. Moreover, there are some
parasites released factors which accumulate inside the
sand fly gut, such as proteophosphoglycans that form a
gel (promastigote secretory gel) [52, 53] and protein-rich
exosomes [54], that can be deposited during transmis-
sion and promote infection. Such factors may enable
Leishmania infection even if exposure to sand fly saliva
offers some protection. It is unlikely that selection bias
in the current study would have weakened any relation-
ship, as only dogs which died within 4 months of infec-
tion were excluded, which are unlikely to have died of
leishmaniasis this rapidly after infection.
Conclusions
The results confirm that anti-saliva antibody responses
are a useful marker of exposure to sand fly bites in en-
demic areas, and could be used in epidemiological stud-
ies, to monitor changes in biting rate due to control
measures [1], and to identify potential wild animal hosts
[7, 55]. Development of recombinant antigen-based as-
says will be needed for widespread use, and the precise
relationship between antibody levels and natural biting
rate needs further study. Anti-saliva antibody responses
were not associated with severity of subsequent infection
in this study.
Abbreviations
CDC: Centers for disease control and prevention; CLA: Crude leishmanial
antigen; kDNA: Kinetoplast DNA; LRT: Likelihood ratio test; OD: Optical
density; PCR: Polymerase chain reaction; SD: Standard deviation; SGH: Salivary
gland homogenate; ZVL: Zoonotic visceral leishmaniasis
Acknowledgements
The authors wish to thank E. Ishikawa, M. R. S. Magalhaes, J. Monteiro, P. Ramos,
R. Baia, L. Salvador, R. N. Pires, and A. Martins for help in the field and laboratory.
J. Travassos da Rosa, R. Lainson and J. Shaw provided facilities in the Instituto
Evandro Chagas, Belém, Brazil.
Funding
The work was funded by the Wellcome Trust. SS was supported by a BBSRC
PhD scholarship to Warwick. The funding bodies played no role in the design
of the study, the collection, analysis, or interpretation of the data, or in writing
the manuscript or decision to submit the paper for publication.
Availability of data and materials
The data supporting the conclusions of this article are included within the
article and raw data will be available from the corresponding author upon
reasonable request.
Authors’ contributions
RJQ, OC, SS designed the study. RJQ, OC, SS, PAB, MER and LMG generated
field and laboratory data. RJQ, SS and OC analysed data. RJQ, OC, SS and
MER prepared the manuscript. All authors read and approved the final
manuscript.
Ethics approval and consent to participate
Canine samples were collected with fully informed consent from dog owners.
Sampling was performed in accordance with UK Home Office guidelines.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Quinnell et al. Parasites & Vectors  (2018) 11:7 Page 10 of 12
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published
maps and institutional affiliations.
Author details
1School of Biology, Faculty of Biological Sciences, University of Leeds, Leeds,
UK. 2Zeeman Institute and School of Life Sciences, University of Warwick,
Coventry, UK. 3Faculty of Infectious Tropical Diseases, Department of Disease
Control, London School of Hygiene and Tropical Medicine, London, UK.
4Division of Biomedical and Life Sciences, Lancaster University, Lancaster, UK.
5Instituto Evandro Chagas, Belém, Pará, Brazil. 6Centro do Ciências Biológicas
e da Saúde, Universidade do Estado do Pará, Belém, Pará, Brazil.
Received: 20 August 2017 Accepted: 11 December 2017
References
1. Gidwani K, Picado A, Rijal S, Singh SP, Roy L, Volfova V, et al. Serological
markers of sand fly exposure to evaluate insecticidal nets against visceral
leishmaniasis in India and Nepal: a cluster-randomized trial. PLoS Negl Trop
Dis. 2011;5:e1296.
2. Drame PM, Poinsignon A, Besnard P, Le Mire J, dos Santos MA, Sow CS, et
al. Human antibody response to Anopheles gambiae saliva: an immuno-
epidemiological biomarker to evaluate the efficacy of insecticide-treated
nets in malaria vector control. Am J Trop Med Hyg. 2010;83:115–21.
3. Maroli M, Feliciangeli MD, Bichaud L, Charrel RN, Gradoni L. Phlebotomine
sandflies and the spreading of leishmaniases and other diseases of public
health concern. Med Vet Entomol. 2013;27:123–47.
4. Alvar J, Velez ID, Bern C, Herrero M, Desjeux P, Cano J, et al. Leishmaniasis
worldwide and global estimates of its incidence. PLoS One. 2012;7:e35671.
5. Rohousova I, Ozensoy S, Ozbel Y, Volf P. Detection of species-specific
antibody response of humans and mice bitten by sand flies. Parasitology.
2005;130:493–9.
6. Barral A, Honda E, Caldas A, Costa J, Vinhas V, Rowton ED, et al. Human
immune response to sand fly salivary gland antigens: a useful
epidemiological marker? Am J Trop Med Hyg. 2000;62:740–5.
7. Gomes RB, Mendonca IL, Silva VC, Ruas J, Silva MB, Cruz MSP, et al.
Antibodies against Lutzomyia longipalpis saliva in the fox Cerdocyon thous
and the sylvatic cycle of Leishmania chagasi. Trans R Soc Trop Med Hyg.
2007;101:127–33.
8. Clements MF, Gidwani K, Kumar R, Hostomska J, Dinesh DS, Kumar V, et al.
Measurement of recent exposure to Phlebotomus argentipes, the vector of
Indian visceral leishmaniasis, by using human antibody responses to sand
fly saliva. Am J Trop Med Hyg. 2010;82:801–7.
9. de Moura TR, Oliveira F, Novais FO, Miranda JC, Clarencio J, Follador I, et al.
Enhanced Leishmania braziliensis infection following pre-exposure to sandfly
saliva. PLoS Negl Trop Dis. 2007;1:e84.
10. Marzouki S, Ben Ahmed M, Boussoffara T, Abdeladhim M, Ben Aleya-Bouafif
N, Namane A, et al. Characterization of the antibody response to the saliva
of Phlebotomus papatasi in people living in endemic areas of cutaneous
leishmaniasis. Am J Trop Med Hyg. 2011;84:653–61.
11. Vlkova M, Rohousova I, Drahota J, Stanneck D, Kruedewagen EM, Mencke N,
et al. Canine antibody response to Phlebotomus perniciosus bites negatively
correlates with the risk of Leishmania infantum transmission. PLoS Negl Trop
Dis. 2011;5:e1344.
12. Hostomska J, Rohousova I, Volfova V, Stanneck D, Mencke N, Volf P. Kinetics
of canine antibody response to saliva of the sand fly Lutzomyia longipalpis.
Vector Borne Zoonotic Dis. 2008;8:443–50.
13. Vinhas V, Andrade BB, Paes F, Bomura A, Clarencio J, Miranda JC, et al. Human
anti-saliva immune response following experimental exposure to the visceral
leishmaniasis vector, Lutzomyia longipalpis. Eur J Immunol. 2007;37:3111–21.
14. Collin N, Gomes R, Teixeira C, Cheng L, Laughinghouse A, Ward JM, et al.
Sand fly salivary proteins induce strong cellular immunity in a natural
reservoir of visceral leishmaniasis with adverse consequences for
Leishmania. PLoS Pathog. 2009;5:e1000441.
15. Vlkova M, Rohousova I, Hostomska J, Pohankova L, Zidkova L, Drahota J,
et al. Kinetics of antibody response in BALB/c and C57BL/6 mice bitten by
Phlebotomus papatasi. PLoS Negl Trop Dis. 2012;6:e1719.
16. Martin-Martin I, Molina R, Jimenez M. Kinetics of anti-Phlebotomus
perniciosus saliva antibodies in experimentally bitten mice and rabbits. PLoS
One. 2015;10:e0140722.
17. Soares BR, Almeida Souza AP, Prates DB, de Oliveira CI, Barral-Netto M,
Miranda JC, et al. Seroconversion of sentinel chickens as a biomarker for
monitoring exposure to visceral leishmaniasis. Sci Rep. 2013;3:2352.
18. Kostalova T, Lestinova T, Sumova P, Vlkova M, Rohousova I, Berriatua E, et al.
Canine antibodies against salivary recombinant proteins of Phlebotomus
perniciosus: a longitudinal study in an endemic focus of canine
leishmaniasis. PLoS Negl Trop Dis. 2015;9:e0003855.
19. Gomes R, Oliveira F. The immune response to sand fly salivary proteins and
its influence on Leishmania immunity. Front Immunol. 2012;3:110.
20. Ockenfels B, Michael E, McDowell MA. Meta-analysis of the effects of insect
vector saliva on host immune responses and infection of vector-transmitted
pathogens: a focus on leishmaniasis. PLoS Negl Trop Dis. 2014;8:e3197.
21. Gomes R, Teixeira C, Teixeira MJ, Oliveira F, Menezes MJ, Silva C, et al.
Immunity to a salivary protein of a sand fly vector protects against the fatal
outcome of visceral leishmaniasis in a hamster model. Proc Natl Acad Sci
USA. 2008;105:7845–50.
22. Oliveira F, Rowton E, Aslan H, Gomes R, Castrovinci PA, Alvarenga PH, et al.
A sand fly salivary protein vaccine shows efficacy against vector-transmitted
cutaneous leishmaniasis in nonhuman primates. Sci Transl Med. 2015;7:
290ra90.
23. Mondragon-Shem K, Al-Salem WS, Kelly-Hope L, Abdeladhim M, Al-Zahrani
MH, Valenzuela JG, et al. Severity of old world cutaneous leishmaniasis is
influenced by previous exposure to sandfly bites in Saudi Arabia. PLoS Negl
Trop Dis. 2015;9:e0003449.
24. Quinnell RJ, Courtenay O. Transmission, reservoir hosts and control of
zoonotic visceral leishmaniasis. Parasitology. 2009;136:1915–34.
25. Quinnell RJ, Courtenay O, Garcez L, Dye C. The epidemiology of canine
leishmaniasis: transmission rates estimated from a cohort study in
Amazonian Brazil. Parasitology. 1997;115:143–56.
26. Courtenay O, Quinnell RJ, Garcez LM, Shaw JJ, Dye C. Infectiousness in a
cohort of Brazilian dogs: why culling fails to control visceral leishmaniasis in
areas of high transmission. J Infect Dis. 2002;186:1314–20.
27. Quinnell RJ, Courtenay O, Davidson S, Garcez L, Lambson B, Ramos P, et al.
Detection of Leishmania infantum by PCR, serology and cellular immune
response in a cohort study of Brazilian dogs. Parasitology. 2001;122:253–61.
28. Carson C, Quinnell RJ, Holden J, Garcez LM, Deborggraeve S, Courtenay O.
Comparison of Leishmania OligoC-TesT PCR with conventional and real-time
PCR for diagnosis of canine Leishmania infection. J Clin Microbiol. 2010;48:
3325–30.
29. Courtenay O, Carson C, Calvo-Bado L, Garcez LM, Quinnell RJ. Heterogeneities
in Leishmania infantum infection: using skin parasite burdens to identify highly
infectious dogs. PLoS Negl Trop Dis. 2014;8:e2583.
30. Quinnell RJ, Dye C. Correlates of the peridomestic abundance of Lutzomyia
longipalpis (Diptera, Psychodidae) in Amazonian Brazil. Med Vet Entomol.
1994;8:219–24.
31. Kelly DW, Mustafa Z, Dye C. Differential application of lambda-cyhalothrin to
control the sandfly Lutzomyia longipalpis. Med Vet Entomol. 1997;11:13–24.
32. Picado A, Ostyn B, Rijal S, Sundar S, Singh P, Chappuis F, et al. Long-lasting
insecticidal nets to prevent visceral leishmaniasis in the Indian subcontinent;
methodological lessons learned from a cluster randomised controlled trial.
PLoS Negl Trop Dis. 2015;9:e0003597.
33. Teixeira C, Gomes R, Collin N, Reynoso D, Jochim R, Oliveira F, et al.
Discovery of markers of exposure specific to bites of Lutzomyia longipalpis,
the vector of Leishmania infantum chagasi in Latin America. PLoS Negl Trop
Dis. 2010;4:e638.
34. Souza AP, Andrade BB, Aquino D, Entringer P, Miranda JC, Alcantara R, et al.
Using recombinant proteins from Lutzomyia longipalpis saliva to estimate
human vector exposure in visceral leishmaniasis endemic areas. PLoS Negl
Trop Dis. 2010;4:e649.
35. Drahota J, Martin-Martin I, Sumova P, Rohousova I, Jimenez M, Molina R, et
al. Recombinant antigens from Phlebotomus perniciosus saliva as markers of
canine exposure to visceral leishmaniases vector. PLoS Negl Trop Dis. 2014;
8:e2597.
36. Marzouki S, Kammoun-Rebai W, Bettaieb J, Abdeladhim M, Hadj Kacem S,
Abdelkader R, et al. Validation of recombinant salivary protein PpSP32 as a
suitable marker of human exposure to Phlebotomus papatasi, the vector of
Leishmania major in Tunisia. PLoS Negl Trop Dis. 2015;9:e0003991.
37. Kostalova T, Lestinova T, Maia C, Sumova P, Vlkova M, Willen L, et al. The
recombinant protein rSP03B is a valid antigen for screening dog exposure
to Phlebotomus perniciosus across foci of canine leishmaniasis. Med Vet
Entomol. 2017;31:88–93.
Quinnell et al. Parasites & Vectors  (2018) 11:7 Page 11 of 12
38. Lainson R, Shaw JJ, Silveira FT, Fraiha H. Leishmaniasis in Brazil. XIX. Visceral
leishmaniasis in the Amazon region, and the presence of Lutzomyia
longipalpis on the island of Marajó, Pará State. Trans R Soc Trop Med Hyg.
1983;77:323–30.
39. Quinnell RJ, Dye C. An experimental study of the peridomestic
distribution of Lutzomyia longipalpis (Diptera, Psychodidae). Bull Entomol
Res. 1994;84:379–82.
40. Mukbel R, Khasharmeh RH, Hijjawi NS, Khalifeh MS, Hatmal MM, McDowell
MA. Human immune response to salivary proteins of wild-caught
Phlebotomus papatasi. Parasitol Res. 2016;115:3345–55.
41. XQ X, Oliveira F, Chang BW, Collin N, Gomes R, Teixeira C, et al. Structure
and function of a “yellow” protein from saliva of the sand fly Lutzomyia
longipalpis that confers protective immunity against Leishmania major
infection. J Biol Chem. 2011;286:32383–93.
42. Courtenay O, Macdonald DW, Lainson R, Shaw JJ, Dye C. Epidemiology of
canine leishmaniasis - a comparative serological study of dogs and foxes in
Amazon Brazil. Parasitology. 1994;109:273–9.
43. Tavares NM, Silva RA, Costa DJ, Pitombo MA, Fukutani KF, Miranda JC, et al.
Lutzomyia longipalpis saliva or salivary protein LJM19 protects against
Leishmania braziliensis and the saliva of its vector, Lutzomyia intermedia.
PLoS Negl Trop Dis. 2011;5:e1169.
44. Aquino DMC, Caldas AJM, Miranda JC, Silva AAM, Barral-Netto M, Barral A.
Epidemiological study of the association between anti-Lutzomyia longipalpis
saliva antibodies and development of delayed-type hypersensitivity to
Leishmania antigen. Am J Trop Med Hyg. 2010;83:825–7.
45. Gomes RB, Brodskyn U, de Oliveira CI, Costa J, Miranda JC, Caldas A, et al.
Seroconversion against Lutzomyia longipalpis saliva concurrent with the
development of anti-Leishmania chagasi delayed-type hypersensitivity. J
Infect Dis. 2002;186:1530–4.
46. Carvalho AM, Fukutani KF, Sharma R, Curvelo RP, Miranda JC, Barral A, et al.
Seroconversion to Lutzomyia intermedia LinB-13 as a biomarker for
developing cutaneous leishmaniasis. Sci Rep. 2017;7:3149.
47. Felipe IMA, de Aquino DMC, Kuppinger O, Santos MDC, Rangel MES,
Barbosa DS, et al. Leishmania infection in humans, dogs and sandflies in a
visceral leishmaniasis endemic area in Maranhão, Brazil. Mem Inst Oswaldo
Cruz. 2011;106:207–11.
48. Soares MRA, Carvalho CC, Silva LA, Lima MSCS, Barral AMP, Rebêlo
JMM, et al. Molecular analysis of natural infection of Lutzomyia
longipalpis in an endemic area for visceral leishmaniasis in Brazil. Cad
Saude Publica. 2011;26:2409–13.
49. Silva EA, Andreotti R, Dias ES, Barros JC, Brazuna JCM. Detection of
Leishmania DNA in phlebotomines captured in Campo Grande, Mato
Grosso do Sul, Brazil. Exp Parasitol. 2008;119:343–8.
50. Rohousova I, Hostomska J, Vlkova M, Kobets T, Lipoldova M, Volf P. The
protective effect against Leishmania infection conferred by sand fly bites is
limited to short-term exposure. Int J Parasitol. 2011;41:481–5.
51. Courtenay O, Peters NC, Rogers ME, Bern C. Combining epidemiology with
basic biology of sand flies, parasites and hosts to inform leishmaniasis
transmission dynamics and control. PLoS Pathog. 2017;13:e1006571.
52. Rogers ME, Corware K, Muller I, Bates PA. Leishmania infantum
proteophosphoglycans regurgitated by the bite of its natural sand fly
vector, Lutzomyia longipalpis, promote parasite establishment in mouse skin
and skin-distant tissues. Microbes Infect. 2010;12:875–9.
53. Rogers ME, Ilg T, Nikolaev AV, Ferguson MAJ, Bates PA. Transmission of
cutaneous leishmaniasis by sand flies is enhanced by regurgitation of fPPG.
Nature. 2004;430:463–7.
54. Atayde VD, Aslan H, Townsend S, Hassani K, Kamhawi S, Olivier M. Exosome
secretion by the parasitic protozoan Leishmania within the sand fly midgut.
Cell Rep. 2015;13:957–67.
55. Martin-Martin I, Molina R, Rohousova I, Drahota J, Volf P, Jimenez M. High
levels of anti-Phlebotomus perniciosus saliva antibodies in different
vertebrate hosts from the re-emerging leishmaniosis focus in Madrid, Spain.
Vet Parasitol. 2014;202:207–16.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Quinnell et al. Parasites & Vectors  (2018) 11:7 Page 12 of 12
